Contributors |
|
ix | |
Preface |
|
xi | |
About the Editors |
|
xv | |
1 Sources and Generation of Surface Contaminants and Their Impact |
|
1 | (50) |
|
|
|
1 | (1) |
|
2 Surface Cleanliness Levels |
|
|
2 | (9) |
|
3 Sources and Generation of Contaminants |
|
|
11 | (16) |
|
|
15 | (5) |
|
3.2 Thin Film or Molecular Contamination |
|
|
20 | (2) |
|
|
22 | (2) |
|
3.4 Microbial Contamination |
|
|
24 | (3) |
|
|
27 | (11) |
|
4.1 Particle Contamination |
|
|
27 | (6) |
|
4.2 Molecular Contamination |
|
|
33 | (1) |
|
|
34 | (2) |
|
4.4 Microbial Contamination |
|
|
36 | (2) |
|
5 Summary and Conclusions |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
38 | (13) |
2 Mid-IR Spectroscopy as a Tool for Cleanliness Validation |
|
51 | (18) |
|
|
|
51 | (2) |
|
2 Principles of Grazing-Angle FTIR |
|
|
53 | (1) |
|
3 Description of the Method |
|
|
54 | (3) |
|
4 Advantages and Disadvantages |
|
|
57 | (1) |
|
4.1 Direct, Real-Time Method |
|
|
57 | (1) |
|
4.2 Detect Anything With An IR Spectrum |
|
|
58 | (1) |
|
|
58 | (1) |
|
4.4 Access to Small Spaces/Flat Surfaces |
|
|
58 | (1) |
|
5 Results and Applications |
|
|
58 | (6) |
|
|
58 | (1) |
|
|
59 | (1) |
|
5.3 Pharmaceutical Applications |
|
|
60 | (1) |
|
5.4 Explosives and Chemical Warfare Agents |
|
|
61 | (1) |
|
|
62 | (1) |
|
5.6 IRRAS by Direct Reflectance |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (4) |
3 Optically Stimulated Electron Emission: A Powerful Tool for Surface Cleanliness Monitoring |
|
69 | (40) |
|
|
|
69 | (2) |
|
|
71 | (11) |
|
|
74 | (1) |
|
2.2 Repeatability and Reproducibility |
|
|
74 | (1) |
|
|
75 | (1) |
|
2.4 Factors Affecting OSEE |
|
|
76 | (6) |
|
3 Photoemitting Materials |
|
|
82 | (5) |
|
3.1 Substrate Emitting and Contaminant Nonemitting |
|
|
82 | (3) |
|
3.2 Substrate Nonemitting and Contaminant Emitting |
|
|
85 | (1) |
|
3.3 Both Substrate and Contaminant Emitting |
|
|
85 | (2) |
|
3.4 Both Substrate and Contaminant Nonemitting |
|
|
87 | (1) |
|
|
87 | (18) |
|
4.1 Surface Cleanliness Monitoring |
|
|
87 | (13) |
|
4.2 Detecting Absence/Presence of Films/Coatings |
|
|
100 | (2) |
|
4.3 Measuring Thickness of Thin Films/Coatings |
|
|
102 | (3) |
|
|
105 | (1) |
|
|
106 | (3) |
4 Methods for Verifying Medical Device Cleanliness |
|
109 | (20) |
|
|
|
109 | (2) |
|
2 Cleaning Issues and Concerns with Medical Devices |
|
|
111 | (2) |
|
|
113 | (2) |
|
4 Cleaning of Metal and Ceramic Components |
|
|
115 | (2) |
|
5 Device Compatibility-Types of Tests and Description |
|
|
117 | (2) |
|
6 Test Methods to Identify Contaminants in Extracts |
|
|
119 | (1) |
|
6.1 Chromatographic Analysis |
|
|
119 | (1) |
|
6.2 Spectrophotometric Analysis |
|
|
119 | (1) |
|
|
120 | (1) |
|
|
120 | (1) |
|
7 Setting Limits and Biological Safety Assessment |
|
|
120 | (2) |
|
|
122 | (1) |
|
9 Sources of Contamination |
|
|
123 | (1) |
|
10 Cleanliness Standards, Nonviable Contamination |
|
|
124 | (1) |
|
10.1 Setting Allowable Limits |
|
|
124 | (1) |
|
10.2 Extraction and Gravimetric Analysis |
|
|
125 | (1) |
|
10.3 Quality Management Systems |
|
|
125 | (1) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
127 | (2) |
5 Cleaning Validation and Its Regulatory Aspects in the Pharmaceutical Industry |
|
129 | (58) |
|
|
|
|
|
131 | (3) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
133 | (1) |
|
2 Good Manufacturing Practice in API Manufacturing |
|
|
134 | (2) |
|
2.1 Designing the Cleaning Process in Manufacturing Plants |
|
|
134 | (1) |
|
2.2 Equipment in the Manufacturing Plant |
|
|
134 | (2) |
|
|
136 | (1) |
|
2.4 Heating, Ventilation, and Air Conditioning System |
|
|
136 | (1) |
|
2.5 Clothing and Footwear |
|
|
136 | (1) |
|
3 Establishing the Acceptance Limits |
|
|
136 | (5) |
|
|
137 | (1) |
|
3.2 Approaches in Establishing the Acceptable Carryover Quantity |
|
|
137 | (1) |
|
3.3 Limits Based on Medical or Pharmacological Potency of the Product |
|
|
138 | (1) |
|
3.4 Limits Based on Toxicity of the Residue |
|
|
139 | (1) |
|
3.5 Risk Levels in Cleaning Validation |
|
|
140 | (1) |
|
3.6 Use of ACQ for a Level 0 or Level 1 Changeover |
|
|
141 | (1) |
|
|
141 | (7) |
|
|
141 | (1) |
|
|
141 | (4) |
|
|
145 | (1) |
|
|
145 | (1) |
|
4.5 Cleaning Porous Equipment |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
147 | (1) |
|
4.8 Postcleaning Equipment Storage |
|
|
147 | (1) |
|
4.9 Microbiological Considerations |
|
|
147 | (1) |
|
|
148 | (1) |
|
4.11 Inspection and Sampling Plan |
|
|
148 | (1) |
|
5 Sampling Methods for Cleaning Validation |
|
|
148 | (3) |
|
|
148 | (1) |
|
|
149 | (2) |
|
|
151 | (1) |
|
5.4 Microbiological Sampling |
|
|
151 | (1) |
|
6 Cleaning Method Specificity |
|
|
151 | (3) |
|
6.1 Recovery in Swab Sampling |
|
|
151 | (1) |
|
6.2 Stability Issues in Cleaning Method |
|
|
152 | (2) |
|
7 Solvents Used for Cleaning |
|
|
154 | (3) |
|
|
155 | (1) |
|
|
155 | (2) |
|
|
157 | (2) |
|
8.1 Grouping of Cleaning Agents |
|
|
157 | (1) |
|
8.2 Selection of a Cleaning Agent |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (7) |
|
|
161 | (1) |
|
|
161 | (1) |
|
9.3 Various Analytical Techniques in Cleaning Validation |
|
|
162 | (4) |
|
10 Cleaning Development Phase |
|
|
166 | (2) |
|
10.1 Standard Operating Procedures |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (1) |
|
11 Cleaning Validation Protocol |
|
|
168 | (9) |
|
11.1 A Model Cleaning Validation Protocol |
|
|
168 | (9) |
|
|
177 | (1) |
|
13 The FDA Cleaning Validation Guideline |
|
|
177 | (2) |
|
|
178 | (1) |
|
|
178 | (1) |
|
14 Effective Cleaning Validation Maintenance Program |
|
|
179 | (2) |
|
14.1 Equipment Cleaning Validation and Maintenance |
|
|
179 | (1) |
|
14.2 Overview of Cleaning Validation Program |
|
|
180 | (1) |
|
14.3 Cleaning Validation Lifecycle Management |
|
|
180 | (1) |
|
14.4 Cleaning Validation Chart |
|
|
181 | (1) |
|
|
181 | (1) |
|
|
182 | (5) |
Index |
|
187 | |